Adjuvant Chemoradiotherapy Versus Adjuvant Chemotherapy for Stage III Gastric or Gastroesophageal Junction Cancer After D2/R0 Resection

Adjuvant Chemoradiotherapy Versus Adjuvant Chemotherapy for Stage III Gastric or Gastroesophageal Junction Cancer After D2/R0 Resection

PurposeTo compare the survival benefit in the adjuvant chemoradiotherapy (CRT) group and chemotherapy (CT) group for stage III gastric or gastroesophageal junction (GEJ) cancer after D2/R0 resection.Methods and MaterialsFrom January 2011 to May 2018, 819 patients (CRT group: 215 patients, CT group:...

Full description

Bibliographic Details
Main Authors: Jinming Shi, Wenzhe Kang, Yuan Tang, Ning Li, Liming Jiang, Lin Yang, Shulian Wang, Yongwen Song, Yueping Liu, Hui Fang, Ningning Lu, Shunan Qi, Bo Chen, Yexiong Li, Yantao Tian, Jing Jin
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Oncology
Subjects:
adjuvant chemoradiotherapy
adjuvant chemotherapy
gastroesophageal junction cancer
gastric cancer
survival analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.916937/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.916937/full

Similar Items